Table 1 Demographic and baseline characteristics of the study participants
Demographic parameter | Indacaterol | Placebo | Placebo/moxifloxacin | ||
|---|---|---|---|---|---|
150 μg | 300 μg | 600 μg | |||
N = 108 | N = 108 | N = 54 | N = 107 | N = 27 | |
Male, n (%) | 76 (70.4) | 75 (69.4) | 37 (68.5) | 76 (71.0) | 18 (66.7) |
Female, n (%) | 32 (29.6) | 33 (30.6) | 17 (31.5) | 31 (29.0) | 9 (33.3) |
Age (yrs), mean (SD) | 37.4 (9.98) | 39.0 (10.28) | 39.1 (9.65) | 38.5 (10.46) | 39.0 (10.58) |
Body mass index (kg/m2), mean (SD) | 26.6 (2.85) | 26.9 (2.78) | 26.7 (2.43) | 26.8 (2.66) | 26.0 (3.17) |
Weight (kg), mean (SD) | 76.6 (11.97) | 77.4 (11.50) | 76.4 (10.26) | 78.0 (11.64) | 73.2 (13.50) |
Race | |||||
○Caucasian (%) | 96 (88.9) | 95 (88.0) | 46 (85.2) | 95 (88.8) | 26 (96.3) |
○Black (%) | 11 (10.2) | 13 (12.0) | 8 (14.8) | 12 (11.2) | 1 (3.7) |
○Other (%) | 1 (0.9) | 0 | 0 | 0 | 0 |